Gene · 5887
Papers1,572
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,572
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A matter of delicate balance: Loss and gain of Cockayne syndrome proteins in premature aging and cancer. | Front Aging | 2022 | 35935726 | PubTator, text mining | PubMed |
| Ubiquitination-coupled liquid phase separation regulates the accumulation of the TRIM family of ubiquitin ligases into cytoplasmic bodies. | PLoS One | 2022 | 35930602 | PubTator, text mining | PubMed |
| Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease. | Life Sci Alliance | 2022 | 35914814 | PubTator, text mining | PubMed |
| The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma. | Front Oncol | 2022 | 35875075 | PubTator, text mining | PubMed |
| LncRNA RP11‑805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR‑34b‑3p and miR‑139‑5p in lung adenocarcinoma. | Oncol Rep | 2022 | 35866595 | PubTator, text mining | PubMed |
| Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases. | Aging Dis | 2022 | 35855336 | PubTator, text mining | PubMed |
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. | Breast Cancer Res | 2022 | 35850772 | PubTator, text mining | PubMed |
| Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases. | Front Cell Neurosci | 2022 | 35846567 | PubTator, text mining | PubMed |
| DNA repair as a shared hallmark in cancer and ageing. | Mol Oncol | 2022 | 35834102 | PubTator, text mining | PubMed |
| C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration. | Front Aging | 2022 | 35821838 | PubTator, text mining | PubMed |
| Proteasome substrate receptors and their therapeutic potential. | Trends Biochem Sci | 2022 | 35817651 | PubTator, text mining | PubMed |
| DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma. | Front Mol Biosci | 2022 | 35813819 | PubTator, text mining | PubMed |
| Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. | Int J Mol Sci | 2022 | 35806243 | PubTator, text mining | PubMed |
| Aldehyde Dehydrogenase 1B1 Is Implicated in DNA Damage Response in Human Colorectal Adenocarcinoma. | Cells | 2022 | 35805102 | PubTator, text mining | PubMed |
| Principles Governing the Phase Separation of Multidomain Proteins. | Biochemistry | 2022 | 35802394 | PubTator, text mining | PubMed |
| Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine. | Genes Dis | 2022 | 35782973 | PubTator, text mining | PubMed |
| Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis. | Front Cell Dev Biol | 2022 | 35769257 | PubTator, text mining | PubMed |
| Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2. | FEBS Lett | 2022 | 35735670 | PubTator, text mining | PubMed |
| MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. | Commun Biol | 2022 | 35710947 | PubTator, text mining | PubMed |
| 26S proteasomes become stably activated upon heat shock when ubiquitination and protein degradation increase. | Proc Natl Acad Sci U S A | 2022 | 35704754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5887/papers?page=11